You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sofosbuvir-velpatasvir drug combination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C, Chronic Trial in Pittsburgh (Sofosbuvir-Velpatasvir Drug Combination)

Recruiting
  • Hepatitis C, Chronic
  • Sofosbuvir-Velpatasvir Drug Combination
  • Pittsburgh, Pennsylvania
    University of Pittsburgh, Magee Womens Hospital
Sep 3, 2021

Hepatitis C, Opioid-Related Disorders, Injection Drug Use Trial in Hazard (Sofosbuvir/velpatasvir (Epclusa®))

Recruiting
  • Hepatitis C
  • +2 more
  • Sofosbuvir/velpatasvir (Epclusa®)
  • Hazard, Kentucky
    ARH Medical Mall
Sep 25, 2022

HCV Infection Trial in Christchurch (SOF/VEL/VOX, VOX, Norgestimate/ethinyl estradiol)

Completed
Has Results
  • HCV Infection
  • Christchurch, New Zealand
    (unnamed)
Aug 17, 2020

Hepatitis C Virus Infection Trial in Korea, Republic of (SOF/VEL, SOF/VEL/VOX)

Completed
Has Results
  • Hepatitis C Virus Infection
  • Seongnam-si, Gyeonggi-D, Korea, Republic of
  • +21 more
Sep 29, 2021

Hepatitis C, Acute Hepatitis C Trial in Germany (Sofosbuvir and Velpatasvir)

Completed
  • Hepatitis C
  • Acute Hepatitis C
  • Sofosbuvir and Velpatasvir
  • Berlin-Friedrichshain, Germany
  • +13 more
Jul 2, 2021

Chronic Hepatitis C Trial in Baltimore (CDI-31244, SOF/VEL)

Completed
Has Results
  • Chronic Hepatitis C
  • Baltimore, Maryland
    Institute of Human Virology University of Maryland
Apr 26, 2021

Chronic Hepatitis C, People Who Inject Drugs Trial in Atlanta (velpatasvir and sofosbuvir once daily for 12 weeks (brand or

Active, not recruiting
  • Chronic Hepatitis C
  • People Who Inject Drugs
  • velpatasvir and sofosbuvir once daily for 12 weeks (brand or branded generic) .
  • Atlanta, Georgia
    Wellstar Atlanta Medical Center
May 31, 2023

Hepatitis C Trial in Sydney (HCV RNA Point of Care, Sofosbuvir/velpatasvir, Glecaprevir/pibrentasvir)

Recruiting
  • Hepatitis C
  • HCV RNA Point of Care
  • +2 more
  • Sydney, New South Wales, Australia
    NUAA NSP
Aug 19, 2022

Hepatitis C, Chronic, Opioid-use Disorder Trial in Pittsburgh (Sofosbuvir/Velpatasvir)

Completed
  • Hepatitis C, Chronic
  • Opioid-use Disorder
  • Pittsburgh, Pennsylvania
    Magee Womens Hospital of UPMC
Aug 19, 2022

Hepatitis C, Chronic, Pregnancy; Infection Trial in Pittsburgh (Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet)

Recruiting
  • Hepatitis C, Chronic
  • Pregnancy; Infection
  • Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet
  • Denver, Colorado
  • +4 more
Dec 3, 2022

Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)

Not yet recruiting
  • Hepatitis C
  • Cirrhosis
  • (no location specified)
Jul 20, 2022

Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus

Recruiting
  • Hepatitis C Virus Infection
  • +3 more
  • Vosevi 400/100/100 Oral Tablet
  • Beigang, Taiwan
  • +14 more
Oct 25, 2021

HCV Coinfection, Liver Disease, HIV Trial in Baltimore (Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX],

Completed
Has Results
  • HCV Coinfection
  • +2 more
  • Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX]
  • Sofosbuvir/Velpatasvir (SOF/VEL)
  • Baltimore, Maryland
    Johns Hopkins Hospital : The John G. Bartlett Specialty Practice
Feb 10, 2022

Cardiovascular Diseases, Hepatitis C, Hiv Trial in Washington, Baltimore (Elbasvir / Grazoprevir Oral Tablet [Zepatier], Cardiac

Active, not recruiting
  • Cardiovascular Diseases
  • +2 more
  • Elbasvir / Grazoprevir Oral Tablet [Zepatier]
  • Cardiac MRI
  • Washington, District of Columbia
  • +1 more
Feb 1, 2023

Liver Transplant, Hepatitis C Trial in Pittsburgh (sofosbuvir/velpatasvir)

Active, not recruiting
  • Liver Transplant
  • Hepatitis C
  • Pittsburgh, Pennsylvania
    UPMC
Oct 6, 2022

End Stage Renal Disease Trial in United States (Epclusa)

Recruiting
  • End Stage Renal Disease
  • Birmingham, Alabama
  • +8 more
Feb 1, 2023

Heart Failure Trial in Los Angeles, Durham, Dallas (Epclusa)

Recruiting
  • Heart Failure
  • Los Angeles, California
  • +2 more
Jan 27, 2022

Hepatitis C Virus Infection Trial in Worldwide (Sofosbuvir (SOF), Ledipasvir/Sofosbuvir (LDV/SOF), Sofosbuvir/Velpatasvir

Terminated
  • Hepatitis C Virus Infection
  • Sofosbuvir (SOF)
  • +3 more
  • Phoenix, Arizona
  • +50 more
Jan 25, 2023

Hepatitis C Virus Infection Trial in Italy, Poland, United Kingdom (SOF/VEL/VOX)

Terminated
Has Results
  • Hepatitis C Virus Infection
  • Firenze, Italy
  • +9 more
Sep 28, 2020

Eliminating HCV Infection Among PWUD

Recruiting
  • Hepatitis C, Chronic
  • Drug Use
  • Vancouver, British Columbia, Canada
    Vancouver Infectious Diseases Centre
Jul 22, 2022

Chronic Hepatitis C Trial in Cairo (Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi] plus Ribavirin, Sofosbuvir /

Recruiting
  • Chronic Hepatitis C
  • Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi] plus Ribavirin
  • Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi]
  • Cairo, Egypt
    Faculty of medicine Helwan University
Jan 3, 2021

Hepatocellular Carcinoma, Hepatitis C, Tumor Recurrence Trial in Alexandria (Velpatasvir/Sofosbuvir)

Active, not recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Alexandria, Egypt
    Alexandria University, Faculty of Medicine
Jan 14, 2022

Hepatitis C, Awaiting Organ Transplant Trial in Boston (Sofosbuvir/velpatasvir, Monitoring)

Recruiting
  • Hepatitis C
  • Awaiting Organ Transplant
  • Boston, Massachusetts
    Brigham and Women's Hospital
Mar 14, 2022

Chronic Hepatitis C Trial in Porto Alegre (Telemedicine, Velpatasvir/Sofosbuvir)

Active, not recruiting
  • Chronic Hepatitis C
  • Porto Alegre, Rio Grande Do Sul, Brazil
    Hospital de Clínicas de Porto Alegre
Aug 24, 2021

Elimination of Hepatitis C Virus Among Users of Substances

Not yet recruiting
  • Hepatitis C in Substance Users
  • Sofosbuvir 400 MG / Velpatasvir 100 MG [Epclusa]
  • (no location specified)
Aug 14, 2022